isradipine has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Futrakul, P | 1 |
| Futrakul, N | 1 |
| Sitprija, V | 1 |
| Sensirivatana, R | 1 |
| Watana, D | 1 |
| Kingwatanakul, P | 1 |
1 other study available for isradipine and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
Improved renal perfusion prevents disease progression in focal segmental glomerulosclerosis.
Topics: Cilazapril; Dipyridamole; Disease Progression; Glomerulosclerosis, Focal Segmental; Heparin; Humans; | 1995 |